Exhibit 10.3
EXHIBIT C
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS. THIS WARRANT WAS ISSUED IN AN EXCHANGE WITH EXISTING SECURITY HOLDERS OF THE ISSUER UNDER SECTION 3(a)(9) OF THE SECURITIES ACT. NEITHER THIS WARRANT NOR SUCH SHARES MAY BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS, AS TO WHICH THE ISSUER MAY REQUIRE AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT.
SPAR GROUP, INC.
COMMON STOCK PURCHASE WARRANT
| Warrant No.: W-2026-1 | Number of Warrant Shares: 9,684,211 |
| Date of Issuance: November 13, 2026 | Exercise Price: $0.38 per share |
| Expiration Date: January 31, 2032 |
Initial Exercise Date: January 31, 2028
WHEREAS, SPAR Group, Inc., a Delaware corporation (the "Company"), SPAR Marketing Force Inc., a Nevada corporation, ReposiTrak, Inc., a Nevada corporation ("TRAK"), and PC Group, Inc., a Utah corporation, are parties to that certain Exchange Agreement, dated as of November 13, 2026 (the "Exchange Agreement"), under which, among other things, the Company has agreed to issue to TRAK or its designee, as additional consideration for the Exchanges, a warrant to purchase shares of the Company's Common Stock; and
WHEREAS, this Warrant is the "Warrant" referred to in Section 3 of the Exchange Agreement and is issued to ReposiTrak, Inc. (together with its registered successors and permitted assigns, the "Holder").
NOW, THEREFORE, in consideration of the Exchanges and the mutual covenants contained herein and in the Exchange Agreement, the Company and the Holder agree as follows. Capitalized terms used but not defined in this Warrant have the meanings given to them in the Exchange Agreement.
| 1. | Grant of Warrant. |
1.1 Warrant Shares. The Company hereby grants to the Holder, and the Holder is entitled, upon the terms and subject to the conditions set forth in this Warrant, to subscribe for and purchase from the Company up to Nine Million Six Hundred Eighty-Four Thousand Two Hundred Eleven (9,684,211) fully paid and nonassessable shares of the common stock of the Company, $0.01 par value per share ("Common Stock") (as adjusted under Section 4, the "Warrant Shares"), at a purchase price of $0.38 per share (as adjusted under Section 4, the "Exercise Price"). The number of Warrant Shares equals the Initial Warrant Shares determined under Section 3 of the Exchange Agreement, being fifty percent (50%) of the aggregate number of Conversion Shares issuable upon conversion of all shares of Series C Preferred issued at the Closing under Sections 1.1 and 1.2 of the Exchange Agreement, rounded up to the next whole share, and shall be conformed at the Closing to the number set forth in the closing capitalization schedule attached as Appendix I to the Exchange Agreement. Consistent with Section 6.5.6 of the Certificate of Designations, the following rules apply: No fractional shares of Common Stock shall be issued upon conversion of Series C Preferred. The Company shall first calculate the aggregate number of Conversion Shares issuable by dividing the aggregate Stated Value of all shares of Series C Preferred included in a single Conversion Notice (as defined in the Certificate of Designations) by the Conversion Price then in effect. Any fractional share of Common Stock resulting from that aggregate calculation shall be rounded up to the next whole share. No separate rounding shall be applied to individual shares of Series C Preferred included in the same Conversion Notice. For purposes of determining the number of shares of Common Stock underlying the Series C Preferred issued at Closing under the Exchange Agreement, including the calculation of the Initial Warrant Shares under Section 3 of the Exchange Agreement, all Series C Preferred issued pursuant to Sections 1.1 and 1.2 of the Exchange Agreement shall be treated as a single aggregate block, regardless of the number of holders or the allocation of those shares among TRAK and its affiliates. The foregoing aggregation rule for the initial warrant calculation shall not limit any holder's right to convert its Series C Preferred in one or more separate conversion transactions after Closing.
1
1.2 Term; Expiration Date. The term of this Warrant is four (4) years, commencing on the Initial Exercise Date (as defined below). This Warrant may be exercised at any time and from time to time on or after January 31, 2028 (the "Initial Exercise Date") and shall expire, if not previously exercised, at 5:00 p.m., Eastern Time, on January 31, 2032 (the "Expiration Date"). Any portion of this Warrant not exercised by the Expiration Date shall be void.
1.3 Vesting. This Warrant shall be fully vested upon issuance, but shall not be exercisable, in whole or in part, before the Initial Exercise Date. Any Notice of Exercise delivered before the Initial Exercise Date shall be of no force or effect.
| 2. | Method of Exercise; Payment. |
2.1 Exercise. The purchase rights represented by this Warrant may be exercised by the Holder, in whole or in part, at any time and from time to time on or after the Initial Exercise Date and on or before the Expiration Date, by delivering to the Company (which may be by email) a duly completed and executed notice of exercise in the form attached as Exhibit A (a "Notice of Exercise"), and (a) paying to the Company, by wire transfer of immediately available funds to an account designated by the Company or by certified or cashier's check, an amount equal to the aggregate Exercise Price for the number of Warrant Shares being purchased, or (b) electing a Net Exercise under Section 2.2. The Holder shall not be required to surrender this Warrant until it has been exercised in full.
2.2 Net Exercise. In lieu of paying the Exercise Price in cash, the Holder may elect to exercise this Warrant, in whole or in part, by a cashless "net exercise" (a "Net Exercise"), in which case the Company shall issue to the Holder a number of Warrant Shares computed using the following formula:
X = Y × (A − B) ÷ A
where X is the number of Warrant Shares to be issued to the Holder; Y is the number of Warrant Shares for which this Warrant is being exercised; A is the Fair Market Value of one share of Common Stock on the trading day immediately preceding the date of the Notice of Exercise; and B is the Exercise Price then in effect. "Fair Market Value" means (i) if the Common Stock is then listed on a national securities exchange, the closing sale price of the Common Stock on the principal exchange on which it is then listed, as reported by Bloomberg L.P. or another reliable source, and (ii) otherwise, the fair market value of one share of Common Stock as determined in good faith by the Board and reasonably acceptable to the Holder. The parties intend that any Net Exercise constitute an exchange with an existing security holder under Section 3(a)(9) of the Securities Act and that, for purposes of Rule 144(d)(3)(x) under the Securities Act, Warrant Shares issued on a Net Exercise be deemed acquired when this Warrant was acquired.
2.3 Delivery of Warrant Shares. Within three (3) business days after the Company's receipt of a Notice of Exercise and, for a cash exercise, the aggregate Exercise Price, the Company shall cause its transfer agent to issue the Warrant Shares so purchased in book-entry form (or, at the Holder's request and if the Warrant Shares may then be issued without a restrictive legend, by credit to the Holder's or its designee's account with The Depository Trust Company) in the name of the Holder or its designee. The Holder shall be deemed the holder of record of such Warrant Shares as of the close of business on the date of exercise. The Company shall pay all issue, stamp and transfer agent fees and taxes in connection with the issuance of Warrant Shares, other than any tax on a transfer to a person other than the Holder.
2.4 Partial Exercise. Upon any partial exercise, the Company shall record the number of Warrant Shares remaining, and, at the Holder's request, shall promptly issue to the Holder a new Warrant on the same terms for the unexercised Warrant Shares.
2.5 Beneficial Ownership Limitation. Notwithstanding anything to the contrary in this Warrant, the Holder shall not be entitled to exercise this Warrant to the extent that, immediately after giving effect to such exercise, the Holder (together with its affiliates and any other persons whose beneficial ownership would be aggregated with the Holder's for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) would hold of record or beneficially own more than 50% of the then-outstanding shares of Common Stock, excluding for this purpose any Common Stock issuable on conversion of Series C Preferred or on exercise of this Warrant or any other warrant, option or right until it is issued (the "Beneficial Ownership Limitation"). Beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder, subject to the exclusion in the preceding sentence. Any purported exercise in violation of this Section 2.5 shall be null and void ab initio to the extent of such excess, and the portion of this Warrant subject to such excess shall remain outstanding and exercisable in accordance with, and subject to the limitations of, this Section 2.5. This Section 2.5 shall terminate and shall not apply to any exercise on or after December 23, 2027.
2
| 3. | Stock Fully Paid; Reservation of Shares. |
All Warrant Shares will, upon issuance in accordance with this Warrant, be duly authorized, validly issued, fully paid and nonassessable, and free from all taxes, liens, charges and preemptive rights with respect to their issuance. Until the Expiration Date, the Company shall at all times keep authorized and reserved for issuance, free of preemptive rights, a number of shares of Common Stock sufficient to permit the exercise of this Warrant in full, without regard to the Beneficial Ownership Limitation. Until the amendment to the Company's certificate of incorporation required by Section 8.5 of the Exchange Agreement becomes effective, the Company's obligations under the preceding sentence shall be satisfied by compliance with Section 2.8 of the Exchange Agreement, and the Company shall cause that amendment to become effective on or before January 31, 2028. If at any time the number of authorized but unissued and unreserved shares of Common Stock is insufficient for that purpose, the Company shall promptly take all corporate action necessary to increase its authorized shares of Common Stock to a sufficient number, including by seeking stockholder approval of an amendment to its certificate of incorporation.
| 4. | Adjustments. |
The number and kind of securities purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows:
4.1 Stock Splits, Dividends and Combinations. If the Company at any time subdivides the outstanding shares of Common Stock or issues a stock dividend or other distribution payable in shares of Common Stock on its outstanding Common Stock, the number of Warrant Shares issuable upon exercise of this Warrant immediately before such subdivision, dividend or distribution shall be proportionately increased and the Exercise Price shall be proportionately decreased; and if the Company at any time combines the outstanding shares of Common Stock (by reverse stock split or otherwise), the number of Warrant Shares issuable upon exercise of this Warrant immediately before such combination shall be proportionately decreased and the Exercise Price shall be proportionately increased. Each adjustment shall become effective at the close of business on the date of such subdivision, dividend, distribution or combination, and the aggregate Exercise Price for all Warrant Shares shall remain unchanged.
4.2 Reclassification. In the case of any reclassification or change of the securities issuable upon exercise of this Warrant (other than a change in par value, or from par value to no par value or from no par value to par value, or a subdivision or combination covered by Section 4.1), the Company shall execute and deliver to the Holder a new Warrant (in form and substance reasonably satisfactory to the Holder), or make appropriate provision without issuing a new Warrant, so that the Holder shall have the right to receive, at a total purchase price not exceeding that payable upon exercise of the unexercised portion of this Warrant, and in lieu of the Warrant Shares theretofore issuable, the kind and amount of shares of stock, other securities, money and property receivable upon such reclassification or change by a holder of the number of shares of Common Stock then purchasable under this Warrant. This Section 4.2 shall similarly apply to successive reclassifications and changes.
4.3 Fundamental Transactions. If the Company (a) merges or consolidates with or into another entity (other than a merger or consolidation in which the Company is the surviving corporation and which does not result in any reclassification or change of the Common Stock), or (b) sells, leases or otherwise transfers all or substantially all of its assets (each, a "Fundamental Transaction"), then, as a condition to the Fundamental Transaction, the Company shall cause the successor or acquiring entity to assume in writing the Company's obligations under this Warrant, and the Holder shall thereafter be entitled to receive upon exercise of this Warrant, at the aggregate Exercise Price then in effect and in lieu of the Warrant Shares, the kind and amount of shares of stock, other securities, money and property that the Holder would have received in the Fundamental Transaction had it exercised this Warrant in full (without regard to the Beneficial Ownership Limitation) immediately before the Fundamental Transaction. The Company shall give the Holder written notice of any Fundamental Transaction at least ten (10) days before the earlier of its record date and its effective date. The Holder shall not be required to exercise this Warrant in connection with any Fundamental Transaction.
| 5. | Notice of Adjustments. |
Whenever the number of Warrant Shares or the Exercise Price is adjusted under Section 4, the Company shall promptly give notice to the Holder setting forth in reasonable detail the event requiring the adjustment, the amount of the adjustment, the method by which the adjustment was calculated, and the number and class of shares purchasable and the Exercise Price after giving effect to the adjustment.
3
| 6. | Fractional Shares. |
No fractional shares shall be issued upon exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall round up to the next whole share.
| 7. | Representations and Warranties of the Holder. |
By accepting this Warrant, the Holder represents and warrants to the Company as follows:
7.1 Investment Intent. This Warrant and the Warrant Shares are being acquired for the Holder's own account, for investment and not with a view to, or for resale in connection with, any distribution thereof in violation of the Securities Act. Upon exercise of this Warrant, the Holder shall, if requested by the Company, confirm in writing that the Warrant Shares are being acquired for investment and not with a view toward distribution in violation of the Securities Act.
7.2 Unregistered Securities. The Holder understands that this Warrant is being issued, together with the Series C Preferred, in exchange for the Note and the Existing Shares under Section 3(a)(9) of the Securities Act, and that any Warrant Shares issued upon a cash exercise of this Warrant will be issued under Section 4(a)(2) of the Securities Act. The Holder further understands that neither this Warrant nor the Warrant Shares have been registered under the Securities Act or any state securities law, that they may be "restricted securities" within the meaning of Rule 144 under the Securities Act, and that they may not be sold or transferred unless registered under the Securities Act or an exemption from registration is available.
7.3 Accredited Investor. The Holder is an "accredited investor" as defined in Rule 501(a) under the Securities Act.
7.4 Sophistication; Economic Risk. The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of acquiring this Warrant and the Warrant Shares and of protecting its interests in connection therewith, and is able to bear the economic risk of that investment.
| 8. | Restrictive Legend; Holding Period. |
8.1 Legend. Unless registered under the Securities Act or eligible for sale under Rule 144 without restriction, the Warrant Shares shall bear a legend in substantially the following form:
THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND MAY NOT BE SOLD OR TRANSFERRED UNLESS REGISTERED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS, AS TO WHICH THE COMPANY MAY REQUIRE AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT.
8.2 Removal of Legend. The Company shall remove the legend promptly when the Warrant Shares may be sold under Rule 144 or an effective registration statement, and shall provide any opinion of counsel or instruction its transfer agent requires for that purpose, at the Company's expense.
8.3 Holding Period. For purposes of Rule 144 under the Securities Act, the parties intend that the holding period of this Warrant include the holding period of the Note and the Existing Shares exchanged for it under the Exchange Agreement. The Company will not take any contrary position unless required by law.
| 9. | Transfer. |
Subject to compliance with applicable securities laws and the legend set forth above, this Warrant and the Warrant Shares may be transferred, in whole or in part, by the Holder, and the Holder may transfer this Warrant to any of its affiliates without the consent of the Company. Any transfer of this Warrant shall be made by surrender of this Warrant to the Company together with a written assignment duly executed by the Holder, whereupon the Company shall issue a new Warrant in the name of the transferee (and, for a partial transfer, a new Warrant to the transferor for the balance), and the Company shall register the transfer in its warrant register. The Company may treat the registered Holder as the owner of this Warrant for all purposes.
4
| 10. | No Rights as Stockholder. |
Except as expressly provided in this Warrant, the Holder, as such, shall not be entitled to vote or receive dividends or be deemed the holder of Common Stock or any other securities of the Company issuable upon exercise of this Warrant for any purpose, nor shall anything in this Warrant confer upon the Holder, as such, any of the rights of a stockholder of the Company, including any right to vote for the election of directors or upon any matter submitted to stockholders, to give or withhold consent to any corporate action, to receive notice of meetings, or to receive dividends or subscription rights, until this Warrant has been exercised and the Warrant Shares purchasable upon such exercise have been issued. Nothing in this Section 10 limits any right of the Holder or its affiliates as a holder of Series C Preferred, Common Stock or otherwise under the Exchange Agreement or the Certificate of Designations.
| 11. | Notices. |
All notices and other communications under this Warrant shall be in writing and shall be given in the manner provided in Section 11.5 of the Exchange Agreement, to the Company or the Holder (or, if the Holder is not a party to the Exchange Agreement, to TRAK on the Holder's behalf) at the addresses set forth on the signature page of the Exchange Agreement, or to such other address as a party may designate by notice given in accordance with this Section 11.
| 12. | Governing Law; Dispute Resolution. |
This Warrant and all actions arising out of or in connection with this Warrant shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflicts of law principles that would require the application of the laws of any other jurisdiction. Any dispute arising out of or relating to this Warrant shall be resolved in accordance with Section 9 of the Exchange Agreement, which is incorporated herein by reference, mutatis mutandis, including the waiver of jury trial set forth therein. The parties agree that money damages would not be an adequate remedy for a breach of the Company's obligations under this Warrant and that the Holder may seek specific performance or injunctive relief under Section 9.3 of the Exchange Agreement.
| 13. | Miscellaneous. |
This Warrant may be amended or waived only in a writing signed by the Company and the Holder. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and permitted assigns. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, an indemnity reasonably satisfactory to the Company (which shall not require a bond), the Company shall issue a new Warrant of like tenor. This Warrant may be executed by electronic signature. The headings in this Warrant are for convenience only and do not affect its interpretation.
[Signature page follows]
5
IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer as of the Date of Issuance.
| SPAR GROUP, INC. | |
| By: /s/ William Linnane______________ Name: William Linnane Title: Chief Executive Officer |
ACKNOWLEDGED AND AGREED, including the representations and warranties in Section 7:
| REPOSITRAK, INC. | |
| By: /s/ Randy Fields_________________ Name: Randy Fields Title: Chief Executive Officer |
6
EXHIBIT A
NOTICE OF EXERCISE
| TO: | SPAR Group, Inc., or its corporate successor in interest |
[Address]
Attention: [Chief Executive Officer]
Email: [●]
| 1. | The undersigned hereby elects to purchase ____________ Warrant Shares pursuant to the terms of the attached Warrant No. W-2026-[1] (the "Warrant"). Capitalized terms used but not defined herein have the meanings given to them in the Warrant. |
| 2. | Method of exercise (check one): |
| ☐ | Cash Exercise: The undersigned tenders herewith, or by concurrent wire transfer, payment in full of the aggregate Exercise Price for the Warrant Shares being purchased. |
| ☐ | Net Exercise: The undersigned elects a Net Exercise under Section 2.2 of the Warrant with respect to the number of Warrant Shares stated in paragraph 1. |
| 3. | Please issue the Warrant Shares in book-entry form in the name of the undersigned or in such other name as is specified below: |
Name: ______________________________________
Address: ____________________________________
DTC participant and account number (if applicable): ________________
| 4. | The undersigned represents and warrants that the Warrant Shares are being acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, any distribution thereof in violation of the Securities Act, and that the representations and warranties of the undersigned set forth in Section 7 of the Warrant are true and correct as of the date hereof. |
| 5. | If this exercise occurs before November 13, 2027, after giving effect to this exercise, the undersigned (together with its affiliates and any other persons whose beneficial ownership would be aggregated with the undersigned's for purposes of Section 13(d) of the Exchange Act) will not beneficially own Common Stock in excess of the Beneficial Ownership Limitation. |
| [HOLDER] | |
| By: ______________________________ Name: ____________________________ Title: _____________________________ |
Date: ______________________
7